Macquarie Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $44.2M | Buy |
7,722,318
+907,236
| +13% | +$5.2M | 0.05% | 447 |
|
2025
Q1 | $55.6M | Buy |
6,815,082
+187,060
| +3% | +$1.53M | 0.07% | 384 |
|
2024
Q4 | $62.4M | Sell |
6,628,022
-341,857
| -5% | -$3.22M | 0.08% | 355 |
|
2024
Q3 | $74.4M | Sell |
6,969,879
-151,343
| -2% | -$1.62M | 0.08% | 336 |
|
2024
Q2 | $70.6M | Buy |
7,121,222
+50,489
| +0.7% | +$501K | 0.08% | 322 |
|
2024
Q1 | $83.3M | Sell |
7,070,733
-144,277
| -2% | -$1.7M | 0.09% | 268 |
|
2023
Q4 | $102M | Buy |
7,215,010
+2,358
| +0% | +$33.5K | 0.12% | 241 |
|
2023
Q3 | $87.7M | Buy |
7,212,652
+290,671
| +4% | +$3.53M | 0.11% | 249 |
|
2023
Q2 | $86.9M | Sell |
6,921,981
-249,054
| -3% | -$3.13M | 0.1% | 273 |
|
2023
Q1 | $79.5M | Buy |
7,171,035
+212,988
| +3% | +$2.36M | 0.09% | 288 |
|
2022
Q4 | $85M | Buy |
6,958,047
+80,286
| +1% | +$980K | 0.1% | 281 |
|
2022
Q3 | $71.8M | Buy |
6,877,761
+110,515
| +2% | +$1.15M | 0.09% | 313 |
|
2022
Q2 | $72.7M | Buy |
6,767,246
+224,367
| +3% | +$2.41M | 0.08% | 333 |
|
2022
Q1 | $62K | Buy |
6,542,879
+248,193
| +4% | +$2.35K | 0.05% | 451 |
|
2021
Q4 | $72.7M | Sell |
6,294,686
-71,898
| -1% | -$830K | 0.06% | 401 |
|
2021
Q3 | $60.8M | Buy |
6,366,584
+77,743
| +1% | +$742K | 0.05% | 460 |
|
2021
Q2 | $60.6M | Buy |
6,288,841
+594,646
| +10% | +$5.73M | 0.05% | 471 |
|
2021
Q1 | $56.3M | Buy |
5,694,195
+2,407,160
| +73% | +$23.8M | 0.08% | 301 |
|
2020
Q4 | $75.9M | Buy |
3,287,035
+2,543,281
| +342% | +$58.7M | 0.11% | 204 |
|
2020
Q3 | $10.5M | Buy |
743,754
+618,632
| +494% | +$8.74M | 0.02% | 634 |
|
2020
Q2 | $1.89M | Sell |
125,122
-23,448
| -16% | -$354K | ﹤0.01% | 1027 |
|
2020
Q1 | $1.37M | Buy |
148,570
+8,068
| +6% | +$74.6K | ﹤0.01% | 1011 |
|
2019
Q4 | $1.37M | Buy |
+140,502
| New | +$1.37M | ﹤0.01% | 1153 |
|